fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

'Brain training' app boosts memory in dementia patients

Written by | 8 Sep 2017

Author: Gary Finnegan A ‘brain training’ game developed by researchers at the University of Cambridge, UK, could help improve the memory of patients in the very earliest stages… read more.

Methylene blue appears to improve short-term memory

Written by | 12 Jul 2016

by Bruce Sylvester: One dosing with methylene blue appears to increase MRI-based response in brain areas that control short-term memory and attention, researchers reported on June 28 in… read more.

Benzodiazepine use not linked to dementia

Written by | 3 Mar 2016

by Bruce Sylvester: Benzodiazepine therapy in older adults is not associated with an increase in dementia risk, researchers reported on Feb. 2, 2016 in The BMJ today.

Rivastigmine treatment appears to improve walking in Parkinson’s patients

Written by | 2 Mar 2016

by Bruce Sylvester: Researchers report that patients treated with the dementia drug rivastigimine are less likely to fall and are much steadier when walking, compared to patients receiving… read more.

EMA Highlights: New guideline on Alzheimer’s medicines

Written by | 17 Feb 2016

by Gary Finnegan: The European Medicines Agency has released a revised guideline on medicines for the treatment of Alzheimer’s disease and other forms of dementia. The publication is… read more.

Diabetes-related dementia linked to other complications

Written by | 28 Jul 2015

by Bruce Sylvester: Persons with high rates of diabetes-related complications appear to  be more likely to develop dementia as they get older than persons with fewer diabetes-related complications, South… read more.

Midlife diabetes onset tied to significant cognitive decline in ensuing 20 years

Written by | 22 Jan 2015

by Bruce Sylvester: Onset of diabetes raises the risk of significant memory and cognitive problems during the following 20 years researchers reported in the Dec. 2 issue of… read more.

Is diabetes linked to cognitive impairment?

Written by | 23 Dec 2014

World Health Matters – Germany – by Gary Finnegan: Mild cognitive impairment (MCI) is twice as common in middle-aged people with diabetes mellitus type 2, according to researchers… read more.

FDA Highlights: Could anti-depressant citalopram affect development of Alzheimer's?

Written by | 17 Jul 2014

by Bruce Sylvester – The selective serotonin reuptake inhibitor (SSRI) citalopram appears to impede development of amyloid beta, a plaque-forming peptide in the brain believed to be involved… read more.

FDA Highlights: Could anti-depressant citalopram affect development of Alzheimer’s?

Written by | 17 Jul 2014

by Bruce Sylvester – The selective serotonin reuptake inhibitor (SSRI) citalopram appears to impede development of amyloid beta, a plaque-forming peptide in the brain believed to be involved… read more.

COPD associated with increased risk for mild cognitive impairment

Written by | 8 May 2014

Researchers have found that a diagnosis of chronic obstructive pulmonary disease (COPD) in older adults was associated with increased risk for mild cognitive impairment (MCI), especially MCI of… read more.

Pain treatment can reduce agitation in people with dementia

Written by | 2 May 2014

Thirty five million people worldwide have dementia, and this number is expected to increase to 115 million by 2050. Agitation and aggression are common in people with dementia,… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.